Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 24, 2026 Filed Aug 27, 2026 00:59 UTC |
Paes-Braga BrianDirector · Chairman & CEO · 10% owner
|
Purchase8.00% Convertible Senior Secured Second Lien Notes due 2031 · Derivative | Not disclosed | $950.00 Strike: $8.66 | $867,000.00 |
DisclosureSEC source: 0001104659-26-101780 · tm2624123-1_4seq1.xml · derivative · entry 1 Paes-Braga Brian · CIK 0002122616 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Shares · 100,086 shares Expires 2031-09-15 Read SEC document |
| July 13, 2026 Filed Jul 16, 2026 00:53 UTC |
Hess Michael BernardDirector
|
GrantStock Option (right to buy) · Derivative | 1,000,000 | $0.00 Strike: $5.79 | $0.00 |
DisclosureSEC source: 0001104659-26-084001 · tm2620636-1_4seq1.xml · derivative · entry 3 Hess Michael Bernard · CIK 0002077938 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Shares · 1,000,000 shares Expires 2036-07-12 F3 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in four equal annual installments commencing from July 13, 2026, subject to the Reporting Person's continued service with the Issuer on each such vesting date. Read SEC document |
| July 13, 2026 Filed Jul 16, 2026 00:53 UTC |
Hess Michael BernardDirector
|
GrantCommon Shares | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-084001 · tm2620636-1_4seq1.xml · nonDerivative · entry 1 Hess Michael Bernard · CIK 0002077938 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,500,000 F1 · shares: Includes 1,000,000 performance share units subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches, subject to the Reporting Person's continued service with the Issuer on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:06 UTC |
Sewell Donald RichardPresident & CFO
|
GrantCommon Shares | 3,847 | $13.00 | $50,011.00 |
DisclosureSEC source: 0001104659-26-070102 · tm2616823-3_4seq1.xml · nonDerivative · entry 1 Sewell Donald Richard · CIK 0002122620 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 877,535 F1 · kind: Represents shares purchased by the Reporting Person directly from the Issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:06 UTC |
Paes-Braga BrianDirector · Chairman & CEO · 10% owner
|
GrantCommon Shares | 200,000 | $13.00 | $2,600,000.00 |
DisclosureSEC source: 0001104659-26-070100 · tm2616823-2_4seq1.xml · nonDerivative · entry 1 Paes-Braga Brian · CIK 0002122616 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,610,130 F1 · kind: Represents shares purchased by the Reporting Person directly from the Issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:05 UTC |
O'Neill Brian ThomasDirector
|
GrantCommon Shares | 10,000 | $13.00 | $130,000.00 |
DisclosureSEC source: 0001104659-26-070095 · tm2616823-1_4seq1.xml · nonDerivative · entry 1 O'Neill Brian Thomas · CIK 0002122768 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,164 F1 · kind: Represents shares purchased by the Reporting Person directly from the Issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.